Seaport Therapeutics CEO Reflects on IPO Success
In the 400th episode of The Readout LOUD, Seaport Therapeutics CEO Daphne Zohar joined the hosts to discuss the biotech company's recent successful initial public offering (IPO).
Key Topics Covered in the Episode
Obesity Pill Battle: Eli Lilly vs. Novo Nordisk
The podcast hosts, Elaine, Allison, and Adam, analyzed the intensifying competition between Eli Lilly and Novo Nordisk in the obesity treatment market. Both companies are vying for dominance with their respective GLP-1 receptor agonists, which have shown significant promise in clinical trials.
Cytokinetics Achieves Phase 3 Study Win
The episode highlighted a major milestone for Cytokinetics, which announced a successful outcome in a Phase 3 clinical study. While specific details about the study were not disclosed, the win underscores Cytokinetics' progress in advancing its pipeline of cardiovascular and neuromuscular therapies.
FDA Commissioner Marty Makary Faces White House Troubles
The hosts also discussed the recent controversies surrounding FDA Commissioner Marty Makary, including his reported tensions with the White House. The episode delved into the implications of these challenges for the FDA's regulatory priorities and public health initiatives.
Celebrating 400 Episodes of The Readout LOUD
This milestone episode marks 400 episodes of The Readout LOUD, a leading biotech podcast that provides insights into the latest developments in the industry. The podcast continues to be a go-to resource for biotech professionals, investors, and enthusiasts seeking in-depth analysis and expert commentary.
"This is the 400th episode of your favorite biotech podcast."
Related articles
FDA Drug Center Acting Director Tracy Beth Høeg Departs Amid Leadership Changes
WASHINGTON — The acting director of the Food and Drug Administration’s drug center, Tracy Beth Høeg, is leaving the agency, according to three sources...
Kratom Use Surges in the US: Rising Addiction and Mental Health Concerns
A national study of kratom use in the US found rising popularity among young adults, and it is linked to addiction and mental health issues, according...
STAT+ Roundup: New Hires and Promotions in Biotech and Pharma
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others....
GLP-1 Drugs Linked to Better Breast Cancer Outcomes in Obesity and Diabetes Patients
A recent study shows that GLP-1 drugs may help improve survival rates in people with breast cancer, obesity, and diabetes. Image Credit: Tatsiana Volk...
U.S. Pressures Germany on Drug Prices Amid FDA Restructuring Concerns
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about we...
Mail-Order Abortion Pills Remain Legal Amid Legal Uncertainty
In a discussion about the best fruits, my STAT colleague Alexa Lee and I agreed that peaches have been mid in recent years. Is this just a New York Ci...
FDA Rejects Melanoma Drug RP1 Amid Leadership Controversy Under Makary
The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw th...
U.S. Pressures Germany to Increase Payments for Prescription Drugs Amid Trade Tensions
WASHINGTON — Over a recent breakfast, U.S. officials had a message for the German ambassador: pay more for pharmaceuticals. The meeting, between U.S....